Free Trial
ASX:RHT

Resonance Health (RHT) Stock Price, News & Analysis

Resonance Health logo

About Resonance Health Stock (ASX:RHT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2.57 million shs
Average Volume
N/A
Market Capitalization
$28.50 million
P/E Ratio
168.79
Dividend Yield
5.77%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices in the Asia Pacific, North America, Europe, the Middle East, and Africa. The company offers FerriScan, a non-invasive MRI based system for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) assisted device for the automated real-time assessment of LIC; HepaFat-AI, an AI-trained device for the automated real-time multi-metric measurement of liver-fat; CardiacT2, a dual analysis service with FerriScan for assessing heart iron loading; HepaFat-Scan, a non-invasive MRI-based solution for the assessment of liver-fat in liver tissue; and LiverSmart, a non-invasive MRI-based multi-parametric device combining FerriSmart and HepaFat-AI into a consolidated report. It also provides quantitative imaging measurements and CRO services, such as quality-assured image analysis, project and data management, and issue resolution services; biomarkers, genomics, and laboratory analysis services, as well as works with third party pathology laboratories for blood/sample collection and for standard biochemical/lab safety assessments; design and protocol development, and project management and monitoring services; assessment of subject inclusion or exclusion, evaluating the safety profile of a new therapy, and supporting primary and secondary end-points demonstrating drug efficacy services; and phantoms for the MRI machines. The company serves clinicians for the management of human diseases; and pharmaceutical and therapeutic companies for their clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.

Receive RHT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Resonance Health and its competitors with MarketBeat's FREE daily newsletter.

RHT Stock News Headlines

Resonance Health Ltd.
The next market Nvidia is positioned to dominate …
Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang said, "The ChatGPT moment for robotics is right around the corner." In fact, I believe these robots could impact 65 million Americans lives — this year. And one stock — currently priced around $7 — could be the biggest winner.
Resonance Health Ltd Updates on Securities Conversion
See More Headlines

RHT Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Resonance Health investors own include ZIP (Z1P), Vital Metals (VML), QX Resources (QXR) and DXN (DXN).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
Current Symbol
ASX:RHT
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
168.79
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-1,090,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$8.59 million
Price / Cash Flow
22.50
Book Value
A$0.02 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$28.50 million
Optionable
Not Optionable
Beta
1.32
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (ASX:RHT) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners